InMode Sets Stage for Second Quarter Financial Results
InMode Ltd. (Nasdaq: INMD), a prominent supplier of advanced medical technologies, plans to announce its financial outcomes for the second quarter of 2025. This announcement is expected to come just before the opening of the Nasdaq market.
Details of the Upcoming Conference Call
The scheduled conference call will occur at 8:30 a.m. Eastern Time on a Wednesday. This call aims to delve into the financial results and provide insights directly from key executives.
Expected Revenue Ranges
Preliminary indications suggest that InMode anticipates generating a revenue ranging between $95.4 million and $95.5 million for the second quarter of 2025. This forecast highlights the company’s strategies aboard in a fluctuating market environment.
Revised Full-Year Guidance
The full-year revenue guidance has seen adjustments due to ongoing market volatility and economic uncertainties. The updated projections for the entire year are now between $365 million and $375 million, a reduction from the earlier estimates that anticipated figures between $395 million and $405 million.
Leadership Insights During the Conference
In this session, key leaders from InMode, including CEO Moshe Mizrahy, CFO Yair Malca, and CTO Dr. Michael Kreindel, will provide updates on the company’s financial health, strategic direction, and insights into the medical technology industry.
How to Join the Conference Call
Participants are encouraged to pre-register for the call to streamline the process. Those who register will receive a unique access code that allows immediate entry on the day of the call.
Dial-In Information
For those who choose not to pre-register, various dial-in options will be available to ensure everyone can participate in what is expected to be a comprehensive discussion:
- U.S. Toll-Free: 1-833-316-0562
- International: 1-412-317-5736
Webcast Information
A live webcast of the conference will also be available on InMode’s website, allowing for an interactive experience for online participants.
More About InMode
InMode continues to be at the forefront of innovation in medical technology. The company emphasizes the development of cutting-edge devices that utilize radio frequency technology to enhance both surgical procedures and patient outcomes. InMode's unwavering commitment to quality and innovation reflects in its expanded product lines serving various medical specialties, including plastic surgery and dermatology.
InMode strives to support healthcare professionals with top-tier products that are designed to facilitate significantly less invasive procedures while improving surgical results. Their dedication to developing technologies that meet the evolving needs of their clients establishes the company as a leader in the health technology field.
Frequently Asked Questions
What is the expected revenue for InMode in Q2 2025?
InMode anticipates revenue between $95.4 million and $95.5 million for the second quarter of 2025.
How has InMode revised its full-year revenue guidance?
The new guidance for full-year 2025 revenue is set between $365 million and $375 million, adjusting from previous expectations.
Who will be speaking during the conference call?
CEO Moshe Mizrahy, CFO Yair Malca, and CTO Dr. Michael Kreindel will be addressing participants during the call.
What should participants do to join the conference call?
Participants can pre-register online to receive a unique dial-in code or use provided numbers to join the call without pre-registration.
What kind of technologies does InMode focus on?
InMode develops innovative technologies based on radio frequency for various medical fields, including plastic surgery and dermatology.
